After TIS, what is next?

Welcome to the New Year for TIS holders. Surely 2015 is our year.
I have been amassing a nice parcel for about seven or eight years now. It has been a ride with many highs and lows but surely the ride is nearly over. I have recommended the stock to friends before only for it to disappoint me once again so now, even though we are so close to sales, I do not tell anyone. I am sure that many here in this forum have also been on the ride and will be glad to see it end.
Assuming that it ends soon, where is our next great hope in the biotech field? I thought that over the quiet Christmas and New Year period we could share ideas and leads with each other.
Another stock that I have been following for quite some time, longer then TIS actually, is Uscom (UCM). This company has two great products though for most of its time it has had the one product, the Ultrasonic Cardiac Output Monitor.
This machine replaces invasive methods of measuring cardiac output – operating on a patient to place a device in the arteries near the heart. An operation that costs more than the USCOM machine!
The machine has been peer-reviewed extensively and found to be as accurate as the invasive, Gold Standard techniques.
Professor Brendon Smith now at Bathurst Hospital was an early adopter of the machine when he worked in Broken Hill and is now travelling internationally presenting the Bathurst Protocol. This Protocol rapidly assesses the correct dosing of fluids in treating Sepsis (Blood Poisoning) a common reason for admittance to hospital.
Mortality rates for this condition at Bathurst Hospital are 7% while they are 20-30% at other Australian hospitals. Professor Smith was a finalist in the Australian of the Year 2014 for his work – though he did not win.
There are some competitors to the USCOM machine though they are somewhat inferior or more expensive.
The other product that the company acquired earlier this year was a blood pressure monitor that measures the pressure near the heart. This machine was acquired using shares only and appears to have been a good deal. The machine itself matches others on the market and is significantly cheaper.
Will 2015 be Uscom’s year? I am hoping for 100 % growth. Management has been haphazard to poor over the early years but now seems to have been on the right path for the last 1-2 years. Distributors are being put in place quite rapidly and indications from management are positive and we are “on the cusp” of profitability.
Anyway that is my contribution. What are other people watching? Where will you be hoping for good returns this year?
Any analysis on UCM by the community would also be appreciated as there appear to be some well-informed people on here and I would appreciate your opinion.
Anyway I hope that this sort of post is ok in the “silly season” while we await positive, hopefully, news on TIS.